Los Angeles Talcum Powder Lawsuit: When the Product on the Shelf Was Not What You Were Told
If you are reading this, someone you love probably used Johnson & Johnson baby powder for years — maybe decades. Maybe she dusted it on after every shower. Maybe her mother used it on her as a baby, and she kept using it into adulthood because it was what her family always did. The bottle sat on the bathroom counter her whole life, and nobody ever told her what might be inside it. And then came the diagnosis — ovarian cancer — and the question that does not leave you alone at 2 a.m.: did the powder she trusted cause the disease that killed her?
You are not alone in asking that question. Right now, in a Los Angeles courtroom, three families are putting that question to a jury. Their mothers, wives, and daughters all died of ovarian cancer after decades of perineal talc use. Their cases were combined into a single trial — the second bellwether in California’s coordinated talcum powder proceedings — and the evidence being presented to that jury includes a document that Johnson & Johnson hoped no one would ever see in open court: a 1973 internal memo in which the company’s own executives discussed reports of asbestos contamination in talc mines and weighed whether to switch to a safer alternative like corn starch.
They kept using talc. For fifty more years.
We are Attorney911 — The Manginello Law Firm. We handle toxic tort claims and wrongful death cases in California, and we have built this page for one reason: so that a family sitting at a kitchen table at 2 a.m. can understand what is happening in that Los Angeles courtroom, what the law actually says, what the evidence actually shows, and what to do if their own story sounds like the stories being told to that jury. This is legal information, not legal advice. The consultation is free. We do not get paid unless we win your case. And if you call 1-888-ATTY-911, a live person answers — 24 hours a day, not an answering service.
The 1973 Memo: What Johnson & Johnson Knew, and When They Knew It
The single most powerful piece of evidence in the Los Angeles courtroom right now is a document Johnson & Johnson produced more than fifty years ago. In 1973, the company’s executives circulated an internal memo discussing how to address reports that found asbestos in the talc mines where the company sourced its raw material. The memo shows that J&J’s own leadership was aware that asbestos — a known, recognized human carcinogen classified by the International Agency for Research on Cancer in its highest risk category — was turning up in the supply chain for a product marketed to be dusted on babies.
And the memo shows something even more damning for the company: they considered switching to corn starch. A safer alternative existed. They knew about it. They wrote it down. And then they chose to keep using talc.
That single document does three things in a courtroom:
First, it establishes corporate knowledge. J&J cannot argue it was unaware of asbestos contamination risk in its talc supply chain — its own executives were discussing it in 1973, before many of the women in these lawsuits were even born.
Second, it establishes the availability of a safer alternative. Under California’s product liability framework, a design defect can be proven by showing the product’s risks could have been reduced by adopting a reasonable alternative design — and the 1973 memo is the company’s own written acknowledgment that corn starch was a feasible substitute.
Third, and most powerfully, it is the engine for punitive damages. California permits punitive damages when a defendant acts with malice, oppression, or fraud — and a half-century of continuing to sell a product while internally debating whether the raw material was contaminated with a known carcinogen is exactly the kind of evidence that lets a jury decide whether the company’s conduct crossed that line.
California Civil Code § 3294 permits punitive damages upon a showing of “malice, oppression, or fraud” — standards the 1973 internal memo evidence may satisfy.
California’s Product Liability Framework: Why Los Angeles Is Where These Cases Belong
California is one of the strongest states in the country for a person injured by a defective product. The reason traces back to a 1963 California Supreme Court decision that created the doctrine of strict product liability — the principle that a manufacturer is responsible for injuries caused by its defective products regardless of whether it was negligent. That doctrine, known as the Greenman rule, spread from California to nearly every state in the country, but California remains where it is strongest.
Under California law, a product can be defective in three ways: a manufacturing defect (the specific unit was built wrong), a design defect (the entire product line is unreasonably dangerous), or a failure to warn (the manufacturer did not warn consumers of a known risk). The talc-ovarian cancer cases pursue all three — but the lead theories are design defect and failure to warn.
For design defect, California employs what is called the risk-benefit test. The jury weighs the product’s benefits against its risks and asks whether a reasonable alternative design was available. The 1973 memo — showing J&J considered corn starch — is the reasonable alternative design evidence, supplied by the defendant’s own files.
For failure to warn, the question is whether J&J failed to warn consumers of the ovarian cancer risk and the potential asbestos contamination despite possessing internal knowledge dating to at least 1973. California law holds that a manufacturer has a duty to warn of risks it knows about or reasonably should know about — and a company that circulates an internal memo about asbestos in its talc mines cannot later claim it had no knowledge of the risk.
Two features of California law make Los Angeles an especially favorable venue for these cases. First, California imposes no statutory cap on compensatory or punitive damages in product liability cases. Unlike states that cap non-economic damages or limit punitive awards, a California jury can award the full measure of what it finds the harm to be worth — including punishment damages that scale with the defendant’s conduct, not with an arbitrary ceiling. Second, California’s wrongful death and survival statutes provide two separate recovery mechanisms: the family’s claim for what they lost (companionship, support, the life itself), and the estate’s claim for what the decedent suffered before death (pain, medical costs, the fear of dying). Both can be pursued in a single trial.
The Los Angeles Superior Court manages California’s coordinated talcum powder proceedings against Johnson & Johnson. It has extensive experience with complex mass tort bellwether trials. The jury pool in Los Angeles County is among the most diverse in the nation, and California juries have historically been receptive to corporate knowledge evidence and failure-to-warn narratives — exactly the kind of evidence the 1973 memo supplies.
The first bellwether case in these coordinated proceedings ended on December 12 with a $40 million verdict for the plaintiff. That result established a baseline — not just for what a Los Angeles jury might award in a single talc-ovarian cancer wrongful death case, but for the settlement leverage that follows when a defendant sees a real verdict come back from a real jury. The second bellwether, now underway, combines three wrongful death claims. If causation is established across all three, the aggregate award could substantially exceed the first.
Who Can Be Held Responsible: The Johnson & Johnson Corporate Structure
Johnson & Johnson is not a single company. It is a web of entities deliberately structured to manage — and limit — liability. Understanding that structure matters because naming the wrong entity in a lawsuit can mean the difference between a case with real recovery potential and a case that bounces off a corporate shell.
The parent is Johnson & Johnson — one of the largest health care companies in the world. The entity that historically sold the talc-based baby powder is Johnson & Johnson Consumer Inc., known as JJCI. In 2021, J&J executed what tort lawyers call the “Texas two-step” — a divisional merger under Texas law that split the consumer business into two entities: one that held the valuable assets, and one (called LTL Management LLC) that was assigned the talc liability. LTL then filed for Chapter 11 bankruptcy, attempting to force all 68,000+ talc claimants into a trust-funded settlement that would cap J&J’s exposure and shield it from jury trials.
That bankruptcy was dismissed. J&J tried again with a second filing. Dismissed again. A third attempt, through a renamed entity called Red River Talc LLC, was dismissed on March 31, 2025, by the U.S. Bankruptcy Court for the Southern District of Texas — which found vote-solicitation irregularities and impermissible nonconsensual third-party releases. Three attempts. Three failures. The cases are back in the tort system, where juries — not bankruptcy judges — decide what they are worth.
Meanwhile, J&J spun off its consumer health business into a separate publicly traded company called Kenvue Inc. in 2023. Kenvue now owns brands like Band-Aid, Tylenol, and Listerine, and J&J retained indemnity obligations for the talc liability. What this means for a plaintiff is that the corporate landscape is fluid — the entity that sold the powder, the entity that holds the indemnity, and the entity that holds the assets may all be different companies in different corporate forms.
As of mid-2026, the federal multidistrict litigation — MDL-2738, consolidated before Judge Michael A. Shipp in the District of New Jersey — shows 68,029 actions pending. That number grows monthly. The California coordinated proceedings run separately, in Los Angeles Superior Court, and California counsel remains intact even as plaintiff firms have faced pro hac vice revocations in New Jersey, Florida, Pennsylvania, and Illinois following a federal magistrate judge’s disqualification ruling. California was not affected by those revocations — the lawyers trying these cases in Los Angeles are still in the courtroom.
The Causation Battleground: Why Specific Causation Is the Hardest Fight
If the 1973 memo is the plaintiff’s strongest weapon, specific causation is the defendant’s strongest shield. And right now, that shield is being wielded with unusual aggression.
Here is the difference between general causation and specific causation, in plain English. General causation asks: can this product cause this disease? For talc and ovarian cancer, the scientific evidence includes epidemiological studies showing a modest but consistent association between perineal talc use and ovarian cancer, and the International Agency for Research on Cancer has classified perineal use of talc-based body powder as possibly carcinogenic to humans. General causation is contested, but it is supportable.
Specific causation asks a harder question: did this product cause this particular woman’s ovarian cancer? That is the question that can sink a case — because ovarian cancer has many known risk factors that have nothing to do with talc. BRCA1 and BRCA2 gene mutations. A family history of ovarian or breast cancer. Nulliparity (never having given birth). Endometriosis. Long-term hormone replacement therapy. Obesity. Advancing age. And critically, most ovarian cancers are idiopathic — meaning no specific cause can be identified even after thorough medical investigation.
J&J’s defense team has weaponized this reality. In the federal MDL, lead plaintiffs’ counsel withdrew two specific causation experts after those experts acknowledged that confounding ovarian cancer risk factors impacted the bellwether cases — and that most ovarian cancers are idiopathic. J&J seized on those withdrawals and filed a motion for an order to show cause seeking potential dismissal of all 67,000 talc lawsuits in the MDL. The company’s argument is blunt: if the plaintiffs’ own experts cannot reliably say talc caused a specific woman’s cancer, no jury should hear the case.
That motion is a survival threat to the entire litigation. But it is not a death sentence — and here is why. The California proceedings are separate from the MDL. The California plaintiffs are presenting their own specific causation experts, and those experts must be prepared to do something the withdrawn MDL experts apparently did not do well enough: affirmatively address the confounding risk factors for each individual decedent rather than relying on general causation alone.
A strong specific causation expert in a talc-ovarian cancer case does not just say “talc causes ovarian cancer.” That expert says: “This woman used talc perineally for 30 years. She does not carry a BRCA mutation. She has no family history of ovarian cancer. She had two children. She never used hormone replacement therapy. Her tumor pathology is consistent with the inflammatory mechanism that talc exposure produces. In my opinion, to a reasonable degree of medical certainty, her talc use was a substantial contributing factor to her ovarian cancer.”
That is the fight. And it is the fight that decides whether the 1973 memo becomes a billion-dollar exhibit or a historical footnote.
The Medicine: Ovarian Cancer and the Talc-Asbestos Connection
Ovarian cancer is one of the deadliest cancers that can strike a woman. It is often called the “silent killer” because its symptoms — bloating, pelvic pain, urinary frequency, feeling full quickly — are vague enough that the disease is frequently diagnosed at a late stage, when it has already spread beyond the ovaries. By the time many women learn they have it, the five-year survival window has narrowed dramatically.
The treatment is brutal. Surgery — typically a total abdominal hysterectomy with bilateral salpingo-oophorectomy, meaning the uterus, both fallopian tubes, and both ovaries are removed — followed by chemotherapy, often a platinum-based regimen like carboplatin paired with paclitaxel. For advanced disease, the treatment may include intraperitoneal chemotherapy, targeted therapies like PARP inhibitors, and repeated debulking surgeries. The medical costs run into the hundreds of thousands of dollars. The human costs — the fear, the pain, the lost years — are what a jury is asked to value.
The talc-ovarian cancer theory works like this. Talc particles applied to the perineal area (the genital region) can migrate through the vagina, through the uterus, and through the fallopian tubes to the ovaries. Once there, the particles are not metabolized or cleared — the body cannot break down mineral particles. They sit in the ovarian tissue and provoke a chronic inflammatory response. That inflammation, sustained over years or decades, creates an environment in which cancerous mutations are more likely to occur and less likely to be repaired by the body’s normal defense mechanisms.
If the talc is contaminated with asbestos — and the 1973 memo establishes that J&J knew asbestos was turning up in talc mines — the carcinogenic potential is significantly greater. Asbestos is classified by the IARC as a Group 1 known human carcinogen, and the EPA regulates it under the Toxic Substances Control Act. OSHA regulates asbestos exposure in occupational settings. But cosmetic talc — the powder sold in the baby powder bottle — falls into a regulatory gap. The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act, but the FDA does not require premarket approval or safety testing for cosmetic ingredients, including talc. The FDA has historically not mandated asbestos testing in cosmetic talc. That gap shifts the entire safety burden to the manufacturer — and the plaintiffs argue J&J exploited that regulatory vacuum while possessing internal knowledge of contamination dating to 1973.
The defense exploits a different gap: the gap between general and specific causation. They hire their own experts — oncologists, epidemiologists, gynecologic pathologists — who testify that the association between talc and ovarian cancer is weak, that the studies showing a link are methodologically flawed, and that even if a general association exists, no expert can reliably say that talc — rather than genetics, hormones, age, or pure chance — caused this particular woman’s cancer. They point to the fact that ovarian cancer occurs in women who never used talc, and that many women who used talc for decades never developed ovarian cancer. They argue the disease is idiopathic, and calling it talc-caused is speculation dressed up as science.
The plaintiff’s counter lives in the details. A woman with no genetic risk factors, no family history, no hormonal risk factors, who used talc daily for decades, whose cancer developed in a pattern consistent with the inflammatory mechanism talc produces — that is a specific causation case. A woman with a BRCA mutation and a mother who died of ovarian cancer — that is a harder case, and the defense will spend its energy there. The strength of the specific causation evidence for each individual decedent is what separates a $40 million verdict from a defense verdict, and the California plaintiffs know it.
The Evidence Clock: What Proof Exists and How Fast It Disappears
Every mass tort case is a race against evidence destruction. In talc-ovarian cancer litigation, the evidence is unusual because the exposure happened decades ago — but the proof of it can still exist if someone acts to preserve it before it is legally destroyed or physically lost.
Pathology tissue blocks. When a woman undergoes surgery for ovarian cancer, the tumor is removed and sent to a pathology lab. The tissue is preserved in blocks of paraffin wax — these are called tissue blocks or FFPE blocks. They can be retained for years, sometimes decades, and they are potentially the single most valuable piece of physical evidence in a talc case because a mineralogist can analyze the tissue for the presence of talc and asbestos fibers. If talc particles are found in ovarian tissue, that is direct physical evidence of migration and exposure. But hospital retention periods for tissue blocks vary — some institutions retain them for 10 years, some for 25, some discard them after a shorter period. If the decedent’s surgery was years ago, the tissue blocks may already be gone. A preservation demand to the hospital’s pathology department must go out immediately.
Medical and treatment records. The complete medical record — diagnosis, treatment history, pathology reports, surgical reports, chemotherapy records, imaging — establishes the injury, its severity, and the treatment costs. Hospital retention periods are governed by California law and vary by institution. These records must be subpoenaed before they are purged.
Product purchase and usage history. Specific causation requires evidence of which talc products were used, how frequently, for how long, and by what route (perineal application). This is the hardest evidence to produce because there are rarely receipts for a product bought at the grocery store every month for 30 years. The proof comes from family testimony — the daughter who remembers her mother’s bathroom counter, the husband who bought the bottle, the photographs that show the product in the background. Memory degrades. Products are discarded. Family members pass away. This evidence is time-sensitive in a way that no statute of limitations can capture — the living memory of how a woman used a product decades ago is the most fragile proof in the case.
Corporate documents. The 1973 memo is already in evidence, but the full knowledge timeline — every internal communication, every test result, every executive decision about whether to test for asbestos, whether to warn, whether to switch to corn starch — requires aggressive discovery. J&J’s document retention and potential spoliation risk require a litigation hold to be enforced through the court. Related corroborating documents — testing memos, quality control records, supplier communications, marketing materials targeting women for feminine hygiene use — are the building blocks of both liability and punitive damages.
Marketing and advertising materials. J&J marketed talc-based baby powder to women for feminine hygiene use for decades. The advertising — print ads, television commercials, in-store displays — encouraged the exact use pattern that creates the risk. Historical advertising archives may exist in corporate records, and some materials are already in the public litigation record from prior trials. These materials establish foreseeability and support punitive damages by showing J&J deliberately encouraged the perineal application that the company’s own internal documents flagged as potentially dangerous.
The preservation letter is the tool that freezes this evidence before it disappears. The day a family calls is the day the clock starts working for them instead of against them.
What These Cases Are Worth: Damages and the $40 Million Benchmark
The first California bellwether case ended on December 12 with a $40 million verdict. That number is not a ceiling — it is a floor. It establishes that a Los Angeles jury, hearing the evidence and weighing the harm, valued a single talc-ovarian cancer wrongful death claim at $40 million. The second bellwether combines three wrongful death claims. If the jury finds for the plaintiffs on all three, the aggregate award could be substantially higher — particularly because punitive damages, driven by the 1973 memo, are in play.
California’s damages framework in a wrongful death product liability case includes multiple categories:
Economic damages — the measurable financial losses. Past medical expenses (surgery, chemotherapy, hospitalization, imaging, medications). Future medical expenses that would have been incurred. Lost earnings — the income the decedent would have earned over her expected working life. Lost earning capacity. Funeral and burial costs. These are provable with records and expert economic projections.
Non-economic damages — the human losses no receipt can capture. The decedent’s pain and suffering before death — the fear, the physical pain, the knowledge that she was dying. The family’s loss of love, companionship, comfort, care, assistance, instruction, guidance, counsel, training, and society. The loss of the life the family would have shared. California does not cap these damages in product liability cases, which means the jury can award the full measure of what it finds the harm to be worth.
Punitive damages — the punishment and deterrence award. Under California Civil Code § 3294, punitive damages are available upon a showing of malice, oppression, or fraud. The 1973 memo — showing J&J knew of asbestos contamination risk, considered a safer alternative, and chose to keep selling talc for decades — is the primary punitive damages engine. In the first bellwether, the $40 million verdict reflected the jury’s assessment of both the harm and the company’s conduct. In a three-death case with the same punitive evidence, the exposure scales.
California’s wrongful death and survival statutes provide separate recovery mechanisms. The wrongful death action belongs to the surviving family members and compensates their losses — the support, the companionship, the guidance they would have received. The survival action belongs to the decedent’s estate and recovers the decedent’s pre-death losses — the pain and suffering, the medical expenses, the lost earnings between injury and death. Both can be pursued, and in a case involving years of cancer treatment before death, the survival damages alone can be substantial.
For context, the national talc litigation has produced significant results. In one Missouri case involving 22 women, a jury returned a $4.69 billion verdict against J&J in 2018 — later reduced by the appellate court to approximately $2.12 billion, which the U.S. Supreme Court declined to review in 2021. That reduced figure — approximately $2.1 billion — stands as the largest affirmed talc verdict in the country.
Past results depend on the facts of each case and do not guarantee future outcomes. But the pattern is clear: when juries hear the 1973 memo, when they see the internal documents, when they listen to the families — they respond. The $40 million California verdict and the $2.1 billion affirmed Missouri verdict are not accidents. They are what happens when the evidence reaches a jury.
The Defense Playbook: What Johnson & Johnson Will Argue — and How to Answer It
Johnson & Johnson has one of the most sophisticated defense teams in the world. The lawyers handling these cases are among the best in the business, and they have a playbook that has been refined across thousands of cases. Here are the plays a talc plaintiff should expect — and the counter to each.
Play 1: “Where is the actual evidence of asbestos?” This is the headline question from the trial — the defense challenges the plaintiff to produce physical proof that asbestos was in the specific talc this woman used. The counter is the 1973 memo itself, which establishes that J&J knew asbestos was turning up in its talc supply chain. The question is not whether asbestos was proven in every bottle — it is whether J&J knew the risk existed, failed to test adequately, failed to warn, and continued selling the product. The memo answers that question in the plaintiff’s favor.
Play 2: “Most ovarian cancers are idiopathic.” The defense argues that because the majority of ovarian cancers have no identifiable cause, the plaintiff cannot prove talc caused this one. The counter is a specific causation expert who affirmatively rules out the known confounding factors for the individual decedent — no BRCA mutation, no family history, no hormonal risk factors — and ties the cancer to the inflammatory mechanism talc exposure produces. The expert must do the differential diagnosis work, not just assert a general link.
Play 3: Expert disqualification under Daubert. J&J has already succeeded in getting two “marquee” specific causation experts withdrawn in the MDL. They will challenge every plaintiff expert in every case. The counter is expert preparation that anticipates every Daubert challenge — methodology grounded in peer-reviewed literature, differential diagnosis that addresses confounders, opinions stated to a reasonable degree of medical certainty, and a curriculum vitae that withstands scrutiny.
Play 4: The bankruptcy shield. J&J tried three times to wall these cases off in a bankruptcy proceeding that would have capped liability and eliminated jury trials. All three attempts failed. The counter is to keep the cases in the tort system, where juries — not bankruptcy trusts — decide value. The dismissals of LTL Management and Red River Talc are public record, and the cases are back where they belong.
Play 5: The recorded statement trap. Early in a claim, a representative may contact the family asking to “just get your story” about product usage. The call is recorded. The questions are designed to elicit uncertainty — “Are you sure it was Johnson & Johnson brand? Could it have been a store brand? How often, exactly? You’re not sure?” — and those uncertainties become defense exhibits at trial. The counter is to never give a recorded statement without counsel. The first call a family makes should be to a lawyer, not to the company’s claims department.
Play 6: The “you have plenty of time” delay. The company may suggest there is no rush — that the litigation will take years and there is time to decide. But evidence dies. Tissue blocks are discarded. Memories fade. Witnesses pass away. The statute of limitations in California for personal injury and wrongful death is generally two years under Code of Civil Procedure § 335.1, and while the discovery rule may extend the clock in latent disease cases — meaning the deadline may run from when you discovered or should have discovered the connection between talc and cancer, not from the date of exposure — relying on the discovery rule is a legal argument, not a guarantee. The only safe move is to talk to a lawyer early, while the evidence is still alive.
The Proof Story: How a Talcum Powder Case Is Actually Built
Building a talc-ovarian cancer case is not like building a car crash case. There is no police report, no skid marks, no tow yard. The injury happened over decades, not in a split second. The proof comes from a different kind of investigation — one that reaches back through time to reconstruct exposure, establish causation, and hold a corporation accountable for what it knew.
It starts with the preservation letter. The day a family calls, a written demand goes out — to the hospital pathology department, to the treating physicians, to any entity that holds medical records or tissue specimens — ordering them to freeze every document and every sample before routine retention schedules allow destruction. That letter is the difference between a case with physical evidence and a case built on memory alone.
Then comes the records sweep. Medical records — every pathology report, every surgical note, every chemotherapy infusion log, every imaging study. Pharmacy records. Employment records. Anything that documents the decedent’s health history, her risk factors (or the absence of them), and her treatment. The medical record is what the specific causation expert works from — it is the raw material of the differential diagnosis.
Then the exposure reconstruction. Family members are interviewed — not by a claims adjuster, but by people working for the family’s side. Who bought the powder? How often? What brand? Where was it kept? How was it used? Was it applied after bathing, on the perineal area, daily, for decades? Old photographs are pulled — bathroom counters, medicine cabinets, shopping lists. Product containers, if they still exist, are preserved. The exposure narrative is built from the fragments of a life, and it has to be honest, specific, and consistent.
Then the experts. A gynecologic oncologist or pathologist who can testify to specific causation — who has reviewed the medical records, ruled out confounding factors, and can state to a reasonable degree of medical certainty that talc was a substantial contributing factor. A mineralogist who can analyze tissue blocks, if they exist, for talc and asbestos fibers. An epidemiologist who can explain the general causation literature. A life-care planner who can project the cost of treatment. A forensic economist who can calculate lost earnings and earning capacity. Each expert is a piece of the proof, and each must be prepared to survive a Daubert challenge from one of the best defense bars in the country.
Then discovery — the process of forcing J&J to produce the documents the company would prefer to keep in its own files. Internal testing memos. Quality control records. Supplier communications. Executive emails. Marketing materials. The 1973 memo is one document — the full knowledge timeline is hundreds, maybe thousands of documents, and each one is a brick in the wall of both liability and punitive damages.
Then the depositions — where J&J’s executives and scientists sit across a table and answer questions under oath. The safety director explains the company’s testing protocols (or the absence of them). The marketing executive explains why the product was promoted for feminine hygiene use. The scientist explains why the company studied the asbestos question in 1973 and then did not switch to corn starch. Every deposition is a chance to build the record the jury will hear.
And then the trial — where the 1973 memo is held up in front of twelve people from Los Angeles County, and the question is put to them directly: did Johnson & Johnson know its baby powder might contain asbestos, and did it choose to keep selling it anyway?
That is how a case is built. It takes time. It takes expertise. It takes resources. And it takes a family willing to sit through a trial and tell their mother’s story to a room full of strangers. The families doing that right now in Los Angeles are performing a service for every family that comes after them — because every bellwether verdict makes the next case stronger.
Your First Steps: What to Do If You or a Loved One Used Talcum Powder and Received an Ovarian Cancer Diagnosis
If you or someone in your family used talcum powder — especially Johnson & Johnson baby powder — for perineal application over years or decades, and that person was diagnosed with ovarian cancer, there are specific steps that protect a potential claim and specific things to avoid.
Do gather the medical records. If your loved one is still living, request complete copies of all medical records — pathology reports, surgical reports, chemotherapy records, imaging studies. If she has passed, the estate’s personal representative can request them. These records are the foundation of the specific causation case, and they are easier to obtain while the treating institutions still have them in active files.
Do ask whether tissue blocks exist. Contact the pathology department at the hospital where surgery was performed and ask whether paraffin tissue blocks from the ovarian tumor are still retained. If they are, do not let them be destroyed. A preservation demand from a lawyer can freeze them. Those blocks may contain physical evidence of talc and asbestos fibers — the single most powerful specific causation proof available.
Do document the product usage history now. Write down everything you remember about the product use. What brand. What size bottle. Where it was purchased. How often it was used. Where on the body it was applied. When the use started and when it stopped. Who else in the household used it. Whether there are photographs showing the product in the home. Do this now — not in six months, not after the trial, not when you have time. Memory degrades, and the details that seem vivid today will blur.
Do identify potential witnesses. Family members who can testify to the product use. Friends who remember the bathroom counter. Doctors who can speak to the absence of other risk factors. The person who did the shopping. Each witness is a piece of the exposure narrative.
Do not give a recorded statement to anyone from Johnson & Johnson or its representatives. Not the claims department, not an “investigator,” not a “researcher” who called to ask about your experience. Anything you say can become a defense exhibit. The first conversation about your case should be with a lawyer working for you, not with someone working for the company.
Do not sign anything. No release, no authorization, no settlement offer, no “quick resolution” form. A check that arrives before the medical results — or before you understand what your case is worth — is designed to close the case cheaply. Signing it may extinguish your right to pursue the full value of the claim.
Do not wait. California’s statute of limitations for personal injury and wrongful death is generally two years under Code of Civil Procedure § 335.1. The discovery rule may extend that deadline in latent disease cases, but the rule’s application is fact-specific and should not be assumed. Every day that passes is a day closer to evidence destruction, memory degradation, and deadline expiration. The preservation letter goes out the day you call.
Do call. The consultation is free. We do not get paid unless we win your case. And the call goes to a live person — 24 hours a day, 7 days a week. 1-888-ATTY-911.
Frequently Asked Questions
Can I sue Johnson & Johnson if my mother died of ovarian cancer after using baby powder for decades?
Yes — if the connection between her talc use and her cancer can be established through expert testimony, and if the statute of limitations has not expired. The key elements are proof of product use (what brand, how long, what route of application), medical records documenting the cancer diagnosis and treatment, and a specific causation expert who can testify that talc was a substantial contributing factor to her cancer. California’s coordinated talc proceedings are designed for exactly these cases, and the first bellwether produced a $40 million verdict.
How long do I have to file a talcum powder lawsuit in California?
California’s statute of limitations for personal injury and wrongful death is generally two years under Code of Civil Procedure § 335.1. For latent disease cases like cancer that may not be connected to a product exposure for years or decades, the discovery rule may apply — meaning the clock may start when you discovered, or through reasonable diligence should have discovered, the injury and its cause. But the discovery rule’s application is fact-specific and contested, and some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. Do not assume you have time. Talk to a lawyer in your state to confirm the specific deadline for your situation.
What is the 1973 Johnson & Johnson memo and why is it so important?
The 1973 memo is an internal Johnson & Johnson document in which executives discussed reports that asbestos — a known human carcinogen — had been found in the talc mines where the company sourced its raw material. The memo also shows the company considered switching to corn starch, a safer alternative. This document is central to the litigation because it establishes corporate knowledge of the asbestos contamination risk decades before any public disclosure, it shows a safer alternative design was available (supporting the design defect claim), and it is the primary evidence supporting punitive damages by showing the company continued selling the product despite internal knowledge of the risk.
What if my loved one had other ovarian cancer risk factors?
This is the core of the specific causation fight. Ovarian cancer has many known risk factors — BRCA mutations, family history, nulliparity, endometriosis, hormone replacement therapy, obesity, age. The defense will argue these factors, not talc, caused the cancer. The plaintiff’s specific causation expert must perform a differential diagnosis that rules out (or weighs) each confounding factor and explains why talc was a substantial contributing factor despite the other risks. Some cases are stronger than others — a woman with no genetic risk factors and no family history who used talc for 30 years has a stronger specific causation profile than a woman with a BRCA mutation and a mother who died of ovarian cancer. But having a risk factor does not automatically defeat a claim — the question is whether talc was a substantial contributing factor, not the sole cause.
Why is the trial happening in Los Angeles?
The Los Angeles Superior Court manages California’s coordinated talcum powder proceedings against Johnson & Johnson. California is a favorable venue for plaintiffs in product liability mass torts because of its strict product liability framework under the Greenman doctrine, its absence of statutory damage caps, its strong punitive damages standards, and a diverse jury pool that has historically been receptive to corporate knowledge evidence. The first California bellwether produced a $40 million verdict, establishing that Los Angeles juries respond to the evidence in these cases. The California proceedings are separate from the federal MDL in New Jersey, and California counsel has not been affected by the pro hac vice revocations that occurred in other states.
What is the difference between the California cases and the federal MDL?
The federal multidistrict litigation — MDL-2738, before Judge Michael A. Shipp in the District of New Jersey — consolidates pretrial proceedings for more than 68,000 talc cases from across the country. The California coordinated proceedings are separate state court proceedings managed by the Los Angeles Superior Court. The two systems run in parallel. The MDL handles federal cases; the California proceedings handle state cases filed in California. Bellwether trials in both systems produce verdicts that influence settlement value across the entire litigation, but a verdict in one system does not bind the other.
Could Johnson & Johnson try to use bankruptcy again to avoid trials?
J&J has attempted three times to use a bankruptcy filing — through entities called LTL Management LLC and Red River Talc LLC — to force all talc claimants into a trust-funded settlement that would cap the company’s liability and eliminate jury trials. All three attempts were dismissed by bankruptcy courts, most recently on March 31, 2025, when the U.S. Bankruptcy Court for the Southern District of Texas dismissed Red River Talc’s Chapter 11 filing after finding vote-solicitation irregularities and impermissible nonconsensual third-party releases. As of now, the cases are back in the tort system, where juries decide value. Whether J&J attempts a fourth bankruptcy filing is an open question, but the pattern of dismissals makes that strategy increasingly difficult.
What is a bellwether trial and why does it matter to my case?
A bellwether trial is a test case selected from a large group of similar cases to see how a jury responds to the evidence. The outcome does not legally bind the other cases, but it sends a powerful signal about settlement value. When a jury returns a $40 million verdict — as happened in the first California bellwether — the defendant knows that similar juries in the same courthouse may return similar verdicts, which creates pressure to settle the remaining cases rather than face trial after trial. Bellwether plaintiffs take on a burden that benefits every claimant in the litigation, because each verdict builds the settlement leverage that drives global resolution discussions.
How much does it cost to hire a lawyer for a talcum powder case?
We handle these cases on a contingency fee basis. That means the consultation is free, and we do not get paid unless we win your case. Our fee is 33.33% of the recovery before trial and 40% if the case goes to trial. There are no upfront costs. We front the expenses of building the case — expert witnesses, medical records, discovery, depositions — and those costs are recovered from the settlement or verdict. If we do not win, you do not owe us attorney’s fees.
Is it too late to file a claim if my loved one died years ago?
It may not be too late. The discovery rule in latent disease cases can mean the statute of limitations does not start running until you discovered, or should have discovered through reasonable diligence, that the ovarian cancer was connected to talc use. For many families, that connection was not apparent until the litigation and the internal documents became public. But the rule’s application varies by state and by the specific facts of your case, and some states impose an outer deadline that can cut off a claim regardless of discovery. The only way to know for certain is to have a lawyer in your state evaluate the specific timeline. Do not assume it is too late — and do not assume you have plenty of time. Call and find out.
Why Attorney911: Who We Are and What We Bring
We are Attorney911 — The Manginello Law Firm, PLLC. We have been in practice since 2001 — more than 24 years. Our aggregate recoveries exceed $50 million. We take toxic tort, wrongful death, and catastrophic injury cases in California, working with local counsel and pro hac admission where required. We do not have a California office — but we have the resources, the experience, and the network to pursue these cases in California courts, and we have done the work to understand exactly how California’s product liability framework, its coordinated proceedings, and its jury pool operate.
Ralph P. Manginello is our Managing Partner — 27+ years licensed, admitted to federal court in the Southern District of Texas, a journalist before he was a lawyer, and a trial attorney who has spent his career in courtrooms. He approaches every case the way a reporter approaches a story — find the document, find the witness, find the truth — and then fights to put it in front of a jury.
Lupe Peña spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue claims from people exactly like the ones we now represent. He knows how claim valuation works from the inside — how reserves are set, how independent medical examiners are selected, how surveillance is deployed, how delay tactics are engineered. He now uses that knowledge for injured clients. And he conducts full consultations in Spanish — no interpreter needed.
For families facing the asbestos and toxic exposure aspects of these cases — the asbestos contamination in talc, the regulatory framework, the decades of corporate knowledge — our experience in toxic tort and asbestos litigation is directly relevant. The science of asbestos causation, the latency of disease, the corporate knowledge timeline, the regulatory gaps — these are the same building blocks we work with in refinery and industrial exposure cases, applied here to a consumer product that sat on a bathroom shelf.
We serve families in English and in Spanish. Hablamos Español. Lupe conducts full consultations in Spanish without an interpreter, and our staff is bilingual.
The consultation is free. We do not get paid unless we win your case. Call 1-888-ATTY-911 — 24 hours a day, 7 days a week, and a live person answers. Not an answering service. Not a voicemail. A person who can help.
If your mother, your wife, your sister, your daughter used Johnson & Johnson baby powder for years and died of ovarian cancer — or if you used it yourself and received a diagnosis — the evidence is still alive. The 1973 memo is in the courtroom. The first bellwether produced a $40 million verdict. The second is underway. The question is whether your family’s story will be part of what comes next.
Past results depend on the facts of each case and do not guarantee future outcomes. But the law is real, the evidence is real, and the right to a jury trial is real. Call us. Let’s talk about what happened to your family, and what can be done about it.